APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anthelmintic Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anthelmintic Drugs Industry Growth and Trends Forecast to 2032

22 December 202594 pages

Choose your research edition.

Industry ResearchAnthelmintic Drugs Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Anthelmintic Drugs Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Anthelmintic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anthelmintic Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Anthelmintic Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Anthelmintic Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anthelmintic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anthelmintic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anthelmintic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anthelmintic Drugs include Sun Pharmaceutical Industries, Johnson & Johnson, Novartis, Merck, Pfizer, Bayer, Mankind Pharma and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anthelmintic Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anthelmintic Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anthelmintic Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anthelmintic Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anthelmintic Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anthelmintic Drugs Market by Company

Sun Pharmaceutical Industries

Johnson & Johnson

Novartis

Merck

Pfizer

Bayer

Mankind Pharma

Cipla

Anthelmintic Drugs Segment by Type

Oral Drugs

Injectables

Anthelmintic Drugs Segment by Application

For Human

For Animal

Anthelmintic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anthelmintic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anthelmintic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anthelmintic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anthelmintic Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anthelmintic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Drugs Table 2. Major Company of Injectables Table 3. Global Anthelmintic Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Anthelmintic Drugs Sales by Type (2021-2026) & (k units) Table 5. Global Anthelmintic Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Anthelmintic Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Anthelmintic Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Anthelmintic Drugs Price by Type (2021-2026) & (US$/unit) Table 9. Global Anthelmintic Drugs Sales by Type (2027-2032) & (k units) Table 10. Global Anthelmintic Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Anthelmintic Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Anthelmintic Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Anthelmintic Drugs Price by Type (2027-2032) & (US$/unit) Table 14. North America Anthelmintic Drugs Sales by Type (2021-2026) & (k units) Table 15. North America Anthelmintic Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Anthelmintic Drugs Sales by Type (2021-2026) & (k units) Table 17. Europe Anthelmintic Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Anthelmintic Drugs Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Anthelmintic Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Anthelmintic Drugs Sales by Type (2021-2026) & (k units) Table 21. Latin America Anthelmintic Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Anthelmintic Drugs Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Anthelmintic Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Anthelmintic Drugs Industry Trends Table 25. Anthelmintic Drugs Industry Drivers Table 26. Anthelmintic Drugs Industry Opportunities and Challenges Table 27. Anthelmintic Drugs Industry Restraints Table 28. Global Anthelmintic Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Anthelmintic Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Anthelmintic Drugs Sales by Company (2021-2026) & (k units) Table 31. Global Anthelmintic Drugs Sales Share by Company (2021-2026) Table 32. Global Anthelmintic Drugs Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Anthelmintic Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Anthelmintic Drugs Major Company Production Sites and Headquarters Table 35. Global Anthelmintic Drugs Company, Product Type & Application Table 36. Global Anthelmintic Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Anthelmintic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Anthelmintic Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Anthelmintic Drugs Sales by Region (2021-2026) & (k units) Table 41. Global Anthelmintic Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Anthelmintic Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Anthelmintic Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Anthelmintic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Anthelmintic Drugs Sales by Region (2027-2032) & (k units) Table 46. Global Anthelmintic Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Anthelmintic Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Anthelmintic Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Anthelmintic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Anthelmintic Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Anthelmintic Drugs Sales by Application (2021-2026) & (k units) Table 52. Global Anthelmintic Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Anthelmintic Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Anthelmintic Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Anthelmintic Drugs Price by Application (2021-2026) & (US$/unit) Table 56. Global Anthelmintic Drugs Sales by Application (2027-2032) & (k units) Table 57. Global Anthelmintic Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Anthelmintic Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Anthelmintic Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Anthelmintic Drugs Price by Application (2027-2032) & (US$/unit) Table 61. North America Anthelmintic Drugs Sales by Application (2021-2026) & (k units) Table 62. North America Anthelmintic Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Anthelmintic Drugs Sales by Application (2021-2026) & (k units) Table 64. Europe Anthelmintic Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Anthelmintic Drugs Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Anthelmintic Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Anthelmintic Drugs Sales by Application (2021-2026) & (k units) Table 68. Latin America Anthelmintic Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Anthelmintic Drugs Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Anthelmintic Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Sun Pharmaceutical Industries Company Information Table 72. Sun Pharmaceutical Industries Business Overview Table 73. Sun Pharmaceutical Industries Anthelmintic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Sun Pharmaceutical Industries Anthelmintic Drugs Product Portfolio Table 75. Sun Pharmaceutical Industries Recent Development Table 76. Johnson & Johnson Company Information Table 77. Johnson & Johnson Business Overview Table 78. Johnson & Johnson Anthelmintic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Johnson & Johnson Anthelmintic Drugs Product Portfolio Table 80. Johnson & Johnson Recent Development Table 81. Novartis Company Information Table 82. Novartis Business Overview Table 83. Novartis Anthelmintic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Novartis Anthelmintic Drugs Product Portfolio Table 85. Novartis Recent Development Table 86. Merck Company Information Table 87. Merck Business Overview Table 88. Merck Anthelmintic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Merck Anthelmintic Drugs Product Portfolio Table 90. Merck Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Anthelmintic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Pfizer Anthelmintic Drugs Product Portfolio Table 95. Pfizer Recent Development Table 96. Bayer Company Information Table 97. Bayer Business Overview Table 98. Bayer Anthelmintic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Bayer Anthelmintic Drugs Product Portfolio Table 100. Bayer Recent Development Table 101. Mankind Pharma Company Information Table 102. Mankind Pharma Business Overview Table 103. Mankind Pharma Anthelmintic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Mankind Pharma Anthelmintic Drugs Product Portfolio Table 105. Mankind Pharma Recent Development Table 106. Cipla Company Information Table 107. Cipla Business Overview Table 108. Cipla Anthelmintic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Cipla Anthelmintic Drugs Product Portfolio Table 110. Cipla Recent Development Table 111. North America Anthelmintic Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 112. North America Anthelmintic Drugs Sales by Country (2021-2026) & (k units) Table 113. North America Anthelmintic Drugs Sales Market Share by Country (2021-2026) Table 114. North America Anthelmintic Drugs Sales Forecast by Country (2027-2032) & (k units) Table 115. North America Anthelmintic Drugs Sales Market Share Forecast by Country (2027-2032) Table 116. North America Anthelmintic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Anthelmintic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Anthelmintic Drugs Market Share by Country (2021-2026) Table 119. North America Anthelmintic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Anthelmintic Drugs Market Share Forecast by Country (2027-2032) Table 121. Europe Anthelmintic Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. Europe Anthelmintic Drugs Sales by Country (2021-2026) & (k units) Table 123. Europe Anthelmintic Drugs Sales Market Share by Country (2021-2026) Table 124. Europe Anthelmintic Drugs Sales Forecast by Country (2027-2032) & (k units) Table 125. Europe Anthelmintic Drugs Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Anthelmintic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Anthelmintic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Anthelmintic Drugs Market Share by Country (2021-2026) Table 129. Europe Anthelmintic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Anthelmintic Drugs Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Anthelmintic Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Anthelmintic Drugs Sales by Country (2021-2026) & (k units) Table 133. Asia-Pacific Anthelmintic Drugs Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Anthelmintic Drugs Sales Forecast by Country (2027-2032) & (k units) Table 135. Asia-Pacific Anthelmintic Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Anthelmintic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Anthelmintic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Anthelmintic Drugs Market Share by Country (2021-2026) Table 139. Asia-Pacific Anthelmintic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Anthelmintic Drugs Market Share Forecast by Country (2027-2032) Table 141. Latin America Anthelmintic Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Latin America Anthelmintic Drugs Sales by Country (2021-2026) & (k units) Table 143. Latin America Anthelmintic Drugs Sales Market Share by Country (2021-2026) Table 144. Latin America Anthelmintic Drugs Sales Forecast by Country (2027-2032) & (k units) Table 145. Latin America Anthelmintic Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Anthelmintic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Anthelmintic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Anthelmintic Drugs Market Share by Country (2021-2026) Table 149. Latin America Anthelmintic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Anthelmintic Drugs Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Anthelmintic Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Anthelmintic Drugs Sales by Country (2021-2026) & (k units) Table 153. Middle East and Africa Anthelmintic Drugs Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Anthelmintic Drugs Sales Forecast by Country (2027-2032) & (k units) Table 155. Middle East and Africa Anthelmintic Drugs Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Anthelmintic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Anthelmintic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Anthelmintic Drugs Market Share by Country (2021-2026) Table 159. Middle East and Africa Anthelmintic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Anthelmintic Drugs Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Anthelmintic Drugs Distributors List Table 164. Anthelmintic Drugs Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Anthelmintic Drugs Image Figure 2. Global Anthelmintic Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anthelmintic Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Anthelmintic Drugs Sales (2021-2032) & (k units) Figure 5. Oral Drugs Image Figure 6. Global Oral Drugs Sales YoY Growth (2021-2032) & (k units) Figure 7. Injectables Image Figure 8. Global Injectables Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Anthelmintic Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Anthelmintic Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Anthelmintic Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Anthelmintic Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Anthelmintic Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Anthelmintic Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Anthelmintic Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Anthelmintic Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Anthelmintic Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Anthelmintic Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Anthelmintic Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Anthelmintic Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Anthelmintic Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. For Human Image Figure 24. Global For Human Sales YoY Growth (2021-2032) & (k units) Figure 25. For Animal Image Figure 26. Global For Animal Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Anthelmintic Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Anthelmintic Drugs Market Share by Application 2025 VS 2032 Figure 29. North America Anthelmintic Drugs Sales Market Share in Volume by Application in 2025 Figure 30. North America Anthelmintic Drugs Sales Market Share in Value by Application in 2025 Figure 31. Europe Anthelmintic Drugs Sales Market Share in Volume by Application in 2025 Figure 32. Europe Anthelmintic Drugs Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Anthelmintic Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Anthelmintic Drugs Sales Market Share in Value by Application in 2025 Figure 35. Latin America Anthelmintic Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Anthelmintic Drugs Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Anthelmintic Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Anthelmintic Drugs Sales Market Share in Value by Application in 2025 Figure 39. North America Anthelmintic Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Anthelmintic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Anthelmintic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Anthelmintic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Anthelmintic Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Anthelmintic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Anthelmintic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Anthelmintic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Anthelmintic Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Anthelmintic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Anthelmintic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Anthelmintic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Anthelmintic Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Anthelmintic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Anthelmintic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Anthelmintic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Anthelmintic Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Anthelmintic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Anthelmintic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Anthelmintic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Anthelmintic Drugs Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Anthelmintic Drugs Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Drugs
  • Injectables
Applications
  • For Human
  • For Animal
Companies covered
  • Sun Pharmaceutical Industries
  • Johnson & Johnson
  • Novartis
  • Merck
  • Pfizer
  • Bayer
  • Mankind Pharma
  • Cipla

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anthelmintic Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anthelmintic Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anthelmintic Drugs Market by Type
  6. 1.3.1 Oral Drugs
  7. 1.3.2 Injectables
  8. 1.4 Global Anthelmintic Drugs Market Size by Type
  9. 1.4.1 Global Anthelmintic Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Anthelmintic Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Anthelmintic Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Anthelmintic Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Anthelmintic Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Anthelmintic Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Anthelmintic Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Anthelmintic Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anthelmintic Drugs Industry Trends
  2. 2.2 Anthelmintic Drugs Industry Drivers
  3. 2.3 Anthelmintic Drugs Industry Opportunities and Challenges
  4. 2.4 Anthelmintic Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anthelmintic Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Anthelmintic Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Anthelmintic Drugs Price (2021-2026)
  4. 3.4 Global Anthelmintic Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anthelmintic Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Anthelmintic Drugs Company, Product Type & Application
  7. 3.7 Global Anthelmintic Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anthelmintic Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anthelmintic Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anthelmintic Drugs Tier 1, Tier 2, and Tier 3
4 Anthelmintic Drugs Regional Status and Outlook
  1. 4.1 Global Anthelmintic Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anthelmintic Drugs Historic Market Size by Region
  3. 4.2.1 Global Anthelmintic Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anthelmintic Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anthelmintic Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anthelmintic Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Anthelmintic Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anthelmintic Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anthelmintic Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anthelmintic Drugs by Application
  1. 5.1 Anthelmintic Drugs Market by Application
  2. 5.1.1 For Human
  3. 5.1.2 For Animal
  4. 5.2 Global Anthelmintic Drugs Market Size by Application
  5. 5.2.1 Global Anthelmintic Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Anthelmintic Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Anthelmintic Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Anthelmintic Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Anthelmintic Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Anthelmintic Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Anthelmintic Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Anthelmintic Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sun Pharmaceutical Industries
  2. 6.1.1 Sun Pharmaceutical Industries Company Information
  3. 6.1.2 Sun Pharmaceutical Industries Business Overview
  4. 6.1.3 Sun Pharmaceutical Industries Anthelmintic Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sun Pharmaceutical Industries Anthelmintic Drugs Product Portfolio
  6. 6.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Anthelmintic Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Anthelmintic Drugs Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Anthelmintic Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Anthelmintic Drugs Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Anthelmintic Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck Anthelmintic Drugs Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Anthelmintic Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Anthelmintic Drugs Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer Anthelmintic Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bayer Anthelmintic Drugs Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 Mankind Pharma
  38. 6.7.1 Mankind Pharma Company Information
  39. 6.7.2 Mankind Pharma Business Overview
  40. 6.7.3 Mankind Pharma Anthelmintic Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Mankind Pharma Anthelmintic Drugs Product Portfolio
  42. 6.7.5 Mankind Pharma Recent Developments
  43. 6.8 Cipla
  44. 6.8.1 Cipla Company Information
  45. 6.8.2 Cipla Business Overview
  46. 6.8.3 Cipla Anthelmintic Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Cipla Anthelmintic Drugs Product Portfolio
  48. 6.8.5 Cipla Recent Developments
7 North America by Country
  1. 7.1 North America Anthelmintic Drugs Sales by Country
  2. 7.1.1 North America Anthelmintic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anthelmintic Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Anthelmintic Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anthelmintic Drugs Market Size by Country
  6. 7.2.1 North America Anthelmintic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anthelmintic Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Anthelmintic Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anthelmintic Drugs Sales by Country
  2. 8.1.1 Europe Anthelmintic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anthelmintic Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Anthelmintic Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anthelmintic Drugs Market Size by Country
  6. 8.2.1 Europe Anthelmintic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anthelmintic Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anthelmintic Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anthelmintic Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Anthelmintic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anthelmintic Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anthelmintic Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anthelmintic Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Anthelmintic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anthelmintic Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anthelmintic Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anthelmintic Drugs Sales by Country
  2. 10.1.1 South America Anthelmintic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anthelmintic Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Anthelmintic Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anthelmintic Drugs Market Size by Country
  6. 10.2.1 South America Anthelmintic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anthelmintic Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Anthelmintic Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anthelmintic Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Anthelmintic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anthelmintic Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anthelmintic Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anthelmintic Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Anthelmintic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anthelmintic Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anthelmintic Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anthelmintic Drugs Value Chain Analysis
  2. 12.1.1 Anthelmintic Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anthelmintic Drugs Production Mode & Process
  7. 12.2 Anthelmintic Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anthelmintic Drugs Distributors
  10. 12.2.3 Anthelmintic Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst